Advances in the approach to acute coronary syndromes

Hospital Practice

Volumn 35, Issue 4, 2000, Pages 61-82

  Kong, David F ^a,b   Blazing, Michael A ^a,b   O'Connor, Christopher M ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; AMFEBUTAMONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CLOPIDOGREL; DALTEPARIN; ENOXAPARIN; EPTIFIBATIDE; ESMOLOL; FATTY ACID; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GEMFIBROZIL; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; MEVINOLIN; NADROPARIN; NICOTINE; PROPRANOLOL; PYRIDINE DERIVATIVE; TICLOPIDINE; TIROFIBAN; UNINDEXED DRUG;

AORTA BALLOON; ARTICLE; BLEEDING; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; DIET; DRUG EFFICACY; DRUG MECHANISM; ELECTROCARDIOGRAPHY; GRANULOCYTOPENIA; HEADACHE; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOTENSION; INCIDENCE; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; THROMBOCYTE AGGREGATION INHIBITION; TOBACCO; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0034655377     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.2000.04.192     Document Type: Article

References (14)

1. Antman EM et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335:1342, 1996
2. Braunwald E, U. S. Agency for Health Care Policy and Research, National Heart, Lung, and Blood Institute. Unstable angina: Diagnosis and management Clinical Practice Guideline 10, AHCPR Publication 94-0602, U. S Department of Health and Human Services, Public Health Service, Rockville, Md, 1994
3. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patient at risk of ischaemic events (CAPRIE). Lancet 348:1329, 1996
4. Cavender JB et al. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol 20:287, 1992
5. Cohen M et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 337:447, 1997
6. Downs JR et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615, 1998
7. Kong DF et al. Clinical outcomes of therapeutic agents that block the platelet glycoprotein llb/llla integrin in ischemic heart disease. Circulation 98:2829, 1998
8. Lewis BS et al. Angiogenesis by gene therapy: A new horizon for myocardial revascularization? Cardiovasc Res 35:490,1997
9. Long-Term Irtervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and broad range of initial cholesterol levels. N Engl J Med 339:1349, 1998
10. Mark DB et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann lnt Med 106:793, 1987
11. Organisation to Assess Strategies for Ischaemic Syndromes (OASIS-2) Investigators. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: A randomised trial. Lancet 353:429, 1999
12. PURSUIT Trial Investigators. Inhibition of platelet glycoprotein llb/llla with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein lla/lllb in Unstable Angina: Receptor Suppression Using lntegrilin Therapy. N Engl J Med 339:436, 1998
13. Schreiber TL et al. Cardiologist versus internist management of patients with unstable angina: Treatment patterns and outcomes, J Am Coll Cardiol 26:577, 1995
14. TIMI IIIB Investigators: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial. Thrombolysis in Myocardial Ischemia. Circulation 89:1545, 1994